| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellularly ATP-gated monoatomic cation channel activity | 1.44e-04 | 7 | 53 | 2 | GO:0004931 | |
| GeneOntologyMolecularFunction | ATP-gated ion channel activity | 2.46e-04 | 9 | 53 | 2 | GO:0035381 | |
| GeneOntologyMolecularFunction | histone H4K8 acetyltransferase activity | 3.74e-04 | 11 | 53 | 2 | GO:0043996 | |
| GeneOntologyMolecularFunction | histone H4K5 acetyltransferase activity | 3.74e-04 | 11 | 53 | 2 | GO:0043995 | |
| GeneOntologyMolecularFunction | histone H4K12 acetyltransferase activity | 4.49e-04 | 12 | 53 | 2 | GO:0043997 | |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 1.15e-03 | 19 | 53 | 2 | GO:0005520 | |
| GeneOntologyMolecularFunction | ubiquitin-like ligase-substrate adaptor activity | 1.35e-03 | 82 | 53 | 3 | GO:1990756 | |
| GeneOntologyMolecularFunction | nucleotide receptor activity | 1.54e-03 | 22 | 53 | 2 | GO:0016502 | |
| GeneOntologyMolecularFunction | purinergic nucleotide receptor activity | 1.54e-03 | 22 | 53 | 2 | GO:0001614 | |
| GeneOntologyMolecularFunction | histone H4 acetyltransferase activity | 1.69e-03 | 23 | 53 | 2 | GO:0010485 | |
| GeneOntologyMolecularFunction | sialic acid binding | 1.99e-03 | 25 | 53 | 2 | GO:0033691 | |
| GeneOntologyMolecularFunction | enzyme-substrate adaptor activity | 2.06e-03 | 95 | 53 | 3 | GO:0140767 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 2.33e-03 | 27 | 53 | 2 | GO:0005044 | |
| GeneOntologyCellularComponent | MOZ/MORF histone acetyltransferase complex | 1.36e-04 | 7 | 54 | 2 | GO:0070776 | |
| GeneOntologyCellularComponent | H3 histone acetyltransferase complex | 1.82e-04 | 8 | 54 | 2 | GO:0070775 | |
| MousePheno | limbs/digits/tail phenotype | PRAMEF7 IGF2R P2RX7 ADAMTS9 DNAJC16 INPP5E EPHA2 WNT10A LIPT2 CCN2 LRRK1 RFT1 CMYA5 PRAMEF8 | 1.85e-05 | 1258 | 44 | 14 | MP:0005371 |
| Domain | TSP_1 | 1.03e-06 | 63 | 54 | 5 | PF00090 | |
| Domain | TSP1 | 1.21e-06 | 65 | 54 | 5 | SM00209 | |
| Domain | TSP1_rpt | 1.21e-06 | 65 | 54 | 5 | IPR000884 | |
| Domain | TSP1 | 1.21e-06 | 65 | 54 | 5 | PS50092 | |
| Domain | CTCK_1 | 1.81e-05 | 18 | 54 | 3 | PS01185 | |
| Domain | Cys_knot_C | 5.02e-05 | 25 | 54 | 3 | IPR006207 | |
| Domain | CTCK_2 | 5.02e-05 | 25 | 54 | 3 | PS01225 | |
| Domain | VWFC_1 | 1.52e-04 | 36 | 54 | 3 | PS01208 | |
| Domain | P2X_receptor | 1.71e-04 | 7 | 54 | 2 | PF00864 | |
| Domain | P2X_purnocptor | 1.71e-04 | 7 | 54 | 2 | IPR001429 | |
| Domain | - | 1.71e-04 | 7 | 54 | 2 | 2.60.490.10 | |
| Domain | P2X_RECEPTOR | 1.71e-04 | 7 | 54 | 2 | PS01212 | |
| Domain | P2X_extracellular_dom | 1.71e-04 | 7 | 54 | 2 | IPR027309 | |
| Domain | VWC | 1.79e-04 | 38 | 54 | 3 | SM00214 | |
| Domain | VWFC_2 | 1.79e-04 | 38 | 54 | 3 | PS50184 | |
| Domain | EPL1 | 2.27e-04 | 8 | 54 | 2 | PF10513 | |
| Domain | Enhancer_polycomb-like_N | 2.27e-04 | 8 | 54 | 2 | IPR019542 | |
| Domain | VWF_dom | 2.42e-04 | 42 | 54 | 3 | IPR001007 | |
| Domain | TIL | 5.32e-04 | 12 | 54 | 2 | PF01826 | |
| Domain | C8 | 5.32e-04 | 12 | 54 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 6.27e-04 | 13 | 54 | 2 | IPR014853 | |
| Domain | C8 | 6.27e-04 | 13 | 54 | 2 | SM00832 | |
| Domain | TIL_dom | 7.30e-04 | 14 | 54 | 2 | IPR002919 | |
| Domain | Znf_FYVE_PHD | 8.58e-04 | 147 | 54 | 4 | IPR011011 | |
| Domain | Zinc_finger_PHD-type_CS | 8.79e-04 | 65 | 54 | 3 | IPR019786 | |
| Domain | VWD | 9.59e-04 | 16 | 54 | 2 | SM00216 | |
| Domain | VWF_type-D | 9.59e-04 | 16 | 54 | 2 | IPR001846 | |
| Domain | VWFD | 9.59e-04 | 16 | 54 | 2 | PS51233 | |
| Domain | VWD | 9.59e-04 | 16 | 54 | 2 | PF00094 | |
| Domain | VWC_out | 1.36e-03 | 19 | 54 | 2 | SM00215 | |
| Domain | PRAME_family | 1.36e-03 | 19 | 54 | 2 | IPR026271 | |
| Domain | PWWP | 1.51e-03 | 20 | 54 | 2 | SM00293 | |
| Domain | EPHD | 1.83e-03 | 22 | 54 | 2 | PS51805 | |
| Domain | CT | 1.83e-03 | 22 | 54 | 2 | SM00041 | |
| Domain | PWWP | 2.00e-03 | 23 | 54 | 2 | PF00855 | |
| Domain | PWWP_dom | 2.00e-03 | 23 | 54 | 2 | IPR000313 | |
| Domain | PWWP | 2.17e-03 | 24 | 54 | 2 | PS50812 | |
| Domain | Peptidase_M12B_ADAM-TS | 2.17e-03 | 24 | 54 | 2 | IPR013273 | |
| Domain | Znf_PHD | 2.32e-03 | 91 | 54 | 3 | IPR001965 | |
| Domain | Bromodomain_CS | 2.55e-03 | 26 | 54 | 2 | IPR018359 | |
| Domain | ZF_PHD_2 | 2.62e-03 | 95 | 54 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 2.70e-03 | 96 | 54 | 3 | PS01359 | |
| Domain | VWC | 2.96e-03 | 28 | 54 | 2 | PF00093 | |
| Domain | BROMODOMAIN_1 | 5.12e-03 | 37 | 54 | 2 | PS00633 | |
| Domain | Bromodomain | 5.40e-03 | 38 | 54 | 2 | PF00439 | |
| Domain | BROMODOMAIN_2 | 6.26e-03 | 41 | 54 | 2 | PS50014 | |
| Domain | BROMO | 6.56e-03 | 42 | 54 | 2 | SM00297 | |
| Pubmed | 9.61e-07 | 497 | 54 | 8 | 23414517 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 27312548 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 24090133 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 21471547 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 17996280 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 25692702 | ||
| Pubmed | 5.81e-06 | 75 | 54 | 4 | 20637190 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 25336328 | ||
| Pubmed | E-NPP3 controls plasmacytoid dendritic cell numbers in the small intestine. | 7.09e-06 | 3 | 54 | 2 | 28225814 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 28007459 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 35063404 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 21054221 | ||
| Pubmed | Localization of P2X receptor subtypes 2, 3 and 7 in human urinary bladder. | 7.09e-06 | 3 | 54 | 2 | 26253104 | |
| Pubmed | Endothelial cell markers in patients with pseudoexfoliation syndrome. | 7.09e-06 | 3 | 54 | 2 | 22593709 | |
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 30104958 | ||
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 26677226 | ||
| Pubmed | 2.36e-05 | 5 | 54 | 2 | 17657819 | ||
| Pubmed | TNFRSF25 VWF KLHL7 ADAMTS9 USP9X ZNF197 RAPGEF4 CCN2 MED13L CMYA5 | 2.49e-05 | 1285 | 54 | 10 | 35914814 | |
| Pubmed | 3.54e-05 | 6 | 54 | 2 | 12270951 | ||
| Pubmed | 3.54e-05 | 6 | 54 | 2 | 20508517 | ||
| Pubmed | 4.84e-05 | 622 | 54 | 7 | 14574404 | ||
| Pubmed | Update of P2X receptor properties and their pharmacology: IUPHAR Review 30. | 4.94e-05 | 7 | 54 | 2 | 33125712 | |
| Pubmed | Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes. | 4.94e-05 | 7 | 54 | 2 | 18794358 | |
| Pubmed | Membrane compartments and purinergic signalling: occurrence and function of P2X receptors in lung. | 4.94e-05 | 7 | 54 | 2 | 19076210 | |
| Pubmed | 4.94e-05 | 7 | 54 | 2 | 18657557 | ||
| Pubmed | Go it alone no more--P2X7 joins the society of heteromeric ATP-gated receptor channels. | 4.94e-05 | 7 | 54 | 2 | 17895406 | |
| Pubmed | 4.94e-05 | 7 | 54 | 2 | 34093381 | ||
| Pubmed | Meta-analysis of new genome-wide association studies of colorectal cancer risk. | 4.94e-05 | 7 | 54 | 2 | 21761138 | |
| Pubmed | 1.06e-04 | 10 | 54 | 2 | 12082590 | ||
| Pubmed | 1.61e-04 | 175 | 54 | 4 | 28071719 | ||
| Pubmed | TGF-beta signaling is dynamically regulated during the alveolarization of rodent and human lungs. | 1.83e-04 | 13 | 54 | 2 | 18095342 | |
| Pubmed | 1.83e-04 | 13 | 54 | 2 | 32909945 | ||
| Pubmed | 2.13e-04 | 14 | 54 | 2 | 36347239 | ||
| Pubmed | Role of LTBP4 in alveolarization, angiogenesis, and fibrosis in lungs. | 2.45e-04 | 15 | 54 | 2 | 28684544 | |
| Pubmed | 2.45e-04 | 15 | 54 | 2 | 23218918 | ||
| Pubmed | CXCL12 defines lung endothelial heterogeneity and promotes distal vascular growth. | 2.80e-04 | 16 | 54 | 2 | 36239312 | |
| Pubmed | 2.80e-04 | 16 | 54 | 2 | 19627984 | ||
| Pubmed | Differential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouse. | 3.17e-04 | 17 | 54 | 2 | 23565261 | |
| Pubmed | 3.17e-04 | 17 | 54 | 2 | 37781892 | ||
| Pubmed | 3.56e-04 | 18 | 54 | 2 | 23894331 | ||
| Pubmed | Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos. | 3.56e-04 | 18 | 54 | 2 | 12890732 | |
| Pubmed | Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes. | 3.56e-04 | 18 | 54 | 2 | 29731491 | |
| Pubmed | 3.56e-04 | 18 | 54 | 2 | 14675769 | ||
| Pubmed | Pramel15 facilitates zygotic nuclear DNMT1 degradation and DNA demethylation. | 3.56e-04 | 18 | 54 | 2 | 39181896 | |
| Pubmed | Muscle composition is regulated by a Lox-TGFβ feedback loop. | 3.98e-04 | 19 | 54 | 2 | 25715398 | |
| Pubmed | Coronary Artery Formation Is Driven by Localized Expression of R-spondin3. | 3.98e-04 | 19 | 54 | 2 | 28834739 | |
| Pubmed | Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways. | 3.98e-04 | 19 | 54 | 2 | 28604677 | |
| Pubmed | 4.42e-04 | 20 | 54 | 2 | 26694250 | ||
| Pubmed | 4.42e-04 | 20 | 54 | 2 | 16580637 | ||
| Pubmed | Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells. | 4.42e-04 | 20 | 54 | 2 | 21425410 | |
| Pubmed | ARRDC1 and ARRDC3 act as tumor suppressors in renal cell carcinoma by facilitating YAP1 degradation. | 4.88e-04 | 21 | 54 | 2 | 29416926 | |
| Pubmed | 4.88e-04 | 21 | 54 | 2 | 27270040 | ||
| Pubmed | 5.36e-04 | 22 | 54 | 2 | 31729367 | ||
| Pubmed | 5.36e-04 | 22 | 54 | 2 | 35120648 | ||
| Pubmed | 5.86e-04 | 23 | 54 | 2 | 19480014 | ||
| Pubmed | 5.93e-04 | 105 | 54 | 3 | 9628581 | ||
| Pubmed | 6.39e-04 | 24 | 54 | 2 | 20935629 | ||
| Pubmed | 6.94e-04 | 25 | 54 | 2 | 37451217 | ||
| Pubmed | 6.94e-04 | 25 | 54 | 2 | 29475039 | ||
| Pubmed | Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei. | 6.94e-04 | 25 | 54 | 2 | 12620990 | |
| Pubmed | Tubby family proteins are adapters for ciliary trafficking of integral membrane proteins. | 6.94e-04 | 25 | 54 | 2 | 28154160 | |
| Pubmed | 6.96e-04 | 963 | 54 | 7 | 28671696 | ||
| Pubmed | Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3. | 7.51e-04 | 26 | 54 | 2 | 18500982 | |
| Pubmed | 8.10e-04 | 27 | 54 | 2 | 24391734 | ||
| Pubmed | 8.72e-04 | 28 | 54 | 2 | 25089626 | ||
| Pubmed | Wnt5a potentiates TGF-β signaling to promote colonic crypt regeneration after tissue injury. | 9.35e-04 | 29 | 54 | 2 | 22956684 | |
| Pubmed | Thirteen Ovary-Enriched Genes Are Individually Not Essential for Female Fertility in Mice. | 1.00e-03 | 30 | 54 | 2 | 38786026 | |
| Pubmed | 1.00e-03 | 30 | 54 | 2 | 19282366 | ||
| Pubmed | Atlas of Wnt and R-spondin gene expression in the developing male mouse lower urogenital tract. | 1.00e-03 | 30 | 54 | 2 | 21936019 | |
| Pubmed | LSM14B is essential for oocyte meiotic maturation by regulating maternal mRNA storage and clearance. | 1.14e-03 | 32 | 54 | 2 | 37889087 | |
| Pubmed | 1.36e-03 | 35 | 54 | 2 | 19389355 | ||
| Pubmed | A global genomic transcriptional code associated with CNS-expressed genes. | 1.51e-03 | 318 | 54 | 4 | 16919269 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 1.54e-03 | 1105 | 54 | 7 | 35748872 | |
| Interaction | ASB15 interactions | 2.44e-06 | 37 | 52 | 4 | int:ASB15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | 1.23e-03 | 681 | 54 | 5 | chr1p36 | |
| Cytoband | 1p36.21 | 2.53e-03 | 63 | 54 | 2 | 1p36.21 | |
| GeneFamily | Purinergic receptors P2X | 1.15e-04 | 7 | 43 | 2 | 214 | |
| GeneFamily | PWWP domain containing | 1.24e-03 | 22 | 43 | 2 | 1147 | |
| GeneFamily | PHD finger proteins | 1.27e-03 | 90 | 43 | 3 | 88 | |
| GeneFamily | PRAME family | 1.48e-03 | 24 | 43 | 2 | 686 | |
| Coexpression | PEDRIOLI_MIR31_TARGETS_DN | 2.14e-05 | 413 | 54 | 7 | M2494 | |
| Coexpression | AIZARANI_LIVER_C29_MVECS_2 | 4.41e-05 | 313 | 54 | 6 | M39128 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.62e-05 | 191 | 54 | 5 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.22e-05 | 196 | 54 | 5 | M3008 | |
| Coexpression | EGFR_UP.V1_DN | 5.22e-05 | 196 | 54 | 5 | M2633 | |
| Coexpression | TRAVAGLINI_LUNG_VEIN_CELL | 7.74e-05 | 40 | 54 | 3 | M41663 | |
| ToppCell | Endothelial-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 9.77e-08 | 185 | 54 | 6 | ae49c61f6ecf128fe2a958b8c75c83688da75f59 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.04e-07 | 187 | 54 | 6 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | Control-Endothelial-VE_Venous|Control / Disease state, Lineage and Cell class | 1.18e-07 | 191 | 54 | 6 | 617546cf4883dedf3323e03a53ba5adec334cf8e | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Vein|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-07 | 192 | 54 | 6 | 81baf1c4063469bb0c03a8602b40e387ba7b0dfb | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Vein|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-07 | 192 | 54 | 6 | 717f3d3bbee4d0f64ba1341ee2b00a407ba1e0f3 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-07 | 193 | 54 | 6 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.37e-07 | 196 | 54 | 6 | 5609b2d93172a488b35d854298a3a4e504e17e28 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.46e-07 | 198 | 54 | 6 | 68ee0baa2f5cf239f2356cc59fee9041a7732bba | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.76e-06 | 166 | 54 | 5 | f7926ee266dcbf10df375cd921f1db5a2fa604f8 | |
| ToppCell | COPD-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 2.55e-06 | 179 | 54 | 5 | 9968da1adcb561d9bf167a42ab5d9de85c071c4a | |
| ToppCell | COPD-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 2.55e-06 | 179 | 54 | 5 | e816dd846a6918ec143b57a380c3a47ed073b66e | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-06 | 180 | 54 | 5 | af2bafcd1b2082629de3ea336711add01565c4c4 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-06 | 180 | 54 | 5 | f29a995cf6e1a1836ed68b73258d9370bf3d4434 | |
| ToppCell | Endothelial-A-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.84e-06 | 183 | 54 | 5 | 2c3f2c25c38f0598b4787d2ec335efe00fdc9751 | |
| ToppCell | Control-Endothelial_cells-Pulmonary_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 2.84e-06 | 183 | 54 | 5 | 46be9f96755c7b65aeac061d95d15abeb6466034 | |
| ToppCell | COPD-Endothelial-VE_Venous|COPD / Disease state, Lineage and Cell class | 2.91e-06 | 184 | 54 | 5 | 44d716e7ba46a1ed03f5992631289653f8fd7d5e | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.99e-06 | 185 | 54 | 5 | 808d5e880069aff8866cd2c733b9fe568a37701f | |
| ToppCell | 367C-Endothelial_cells-Endothelial-D|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.15e-06 | 187 | 54 | 5 | 1342bc614bc4045263c2eb0a535a1dd6c64e7abe | |
| ToppCell | 367C-Endothelial_cells-Endothelial-D-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.15e-06 | 187 | 54 | 5 | 7aa206262b14b9f2aaa99e59da38b96c3594d2c9 | |
| ToppCell | Endothelial-A-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 3.15e-06 | 187 | 54 | 5 | fd93f3f4b82dae3bf4eef245bfedc2a9e3251b61 | |
| ToppCell | Endothelial-A-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 3.15e-06 | 187 | 54 | 5 | febe0b99a6a815ce687160a0e7af55228b1d5beb | |
| ToppCell | 390C-Endothelial_cells-Endothelial-D-|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.24e-06 | 188 | 54 | 5 | 50481192da0e9484accb7fcbf9e28a246bb3b80f | |
| ToppCell | Control-Endothelial-VE_Peribronchial|Control / Disease state, Lineage and Cell class | 3.24e-06 | 188 | 54 | 5 | f5b7dbc89f992c13280d36a34935be83906b1bc0 | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 3.24e-06 | 188 | 54 | 5 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-D|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.24e-06 | 188 | 54 | 5 | 30bbd00297de7a2e3e6008aaf37ec0d0617315eb | |
| ToppCell | Control-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 3.32e-06 | 189 | 54 | 5 | f83f7521e377ded1522639e9a35c98b3e2725bac | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.32e-06 | 189 | 54 | 5 | e82211b9dc7540e7a183be2cbcfae39fdf503949 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.32e-06 | 189 | 54 | 5 | e002dbb2138a6264be23f3b8148275a0cef351ef | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.41e-06 | 190 | 54 | 5 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | Control-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 3.41e-06 | 190 | 54 | 5 | 4e30155203b4a8c5e496fcbe9348b67b98ebc625 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.59e-06 | 192 | 54 | 5 | 52acaecd3703166f5ce3b328aff7c82bd142fee4 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.59e-06 | 192 | 54 | 5 | 0aeb5351275c0a91151ea2d52b2cdde172da6731 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-SVEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.59e-06 | 192 | 54 | 5 | c3dda7c48732b0b8bde36de282d64192f5e9b98f | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.68e-06 | 193 | 54 | 5 | 9ba688b35a9ead5d04691b3f3f15484f02dbbd0d | |
| ToppCell | IPF-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 3.68e-06 | 193 | 54 | 5 | ef66a46e7ab44fcc4005a23416e6da478a4cce37 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-A_(Artery)|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.77e-06 | 194 | 54 | 5 | 2e5b195e02dcd5e9432b9a98b22e0478e65b9ba2 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-A_(Artery)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.77e-06 | 194 | 54 | 5 | b6b5b0ab506b05a005ba8a05a3c7f4c725ba9200 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.87e-06 | 195 | 54 | 5 | 56efeb58df19f357d7d5ce87348d4f196a595421 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.87e-06 | 195 | 54 | 5 | 818bc18c5834238e5f733cac6fe928ed0788f57d | |
| ToppCell | (6)_Endothelial-D|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.87e-06 | 195 | 54 | 5 | c0005a5f2dc63a0cc254c45ac89a2f42df6f8bde | |
| ToppCell | ASK428-Endothelial-Endothelium|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.96e-06 | 196 | 54 | 5 | b1a81eddb91fb462360692b7b0a3ba4a947eac40 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.96e-06 | 196 | 54 | 5 | d5d3028fcbfa251a206d17ec33b3b313968f9d79 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.96e-06 | 196 | 54 | 5 | eb8c9a4a5eb21d43ff7b25deae5896c236f669b9 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.06e-06 | 197 | 54 | 5 | 8437c33e2c4a10a1b95343431e48d5e820b1f742 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.06e-06 | 197 | 54 | 5 | 0542badae77d2f606c13cfaf361319495c354351 | |
| ToppCell | (4)_Blood_vessel|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 4.06e-06 | 197 | 54 | 5 | 1b82979a41ef46c814c82527a585900586d71260 | |
| ToppCell | distal-Endothelial-Bronchial_Vessel_1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.06e-06 | 197 | 54 | 5 | f45a93b5ad80a16b760acbaa6467648ffc05a0d3 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.06e-06 | 197 | 54 | 5 | 76b61e60a757e58b465569538e632d6d9953e89a | |
| ToppCell | 356C-Endothelial_cells|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.06e-06 | 197 | 54 | 5 | f20eda534b2b28986790b28ce150ca3ba067593a | |
| ToppCell | 390C-Endothelial_cells|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.06e-06 | 197 | 54 | 5 | aa381acea0f7882d39435a6f713386bf0588b5f8 | |
| ToppCell | metastatic_Brain-Endothelial_cells|metastatic_Brain / Location, Cell class and cell subclass | 4.17e-06 | 198 | 54 | 5 | 97ef7946ef11ac93318c1dd46b548dc01e5a6aba | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.17e-06 | 198 | 54 | 5 | 3ae1e2b4ca77b94eaa24a8c990780aff47dface6 | |
| ToppCell | Bronchial_Biopsy-Endothelial-Endothelial|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.17e-06 | 198 | 54 | 5 | d4a4e5c358d26d09ff27541ce49d0db75c1cd08e | |
| ToppCell | distal-1-Endothelial-Bronchial_Vessel_1|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.17e-06 | 198 | 54 | 5 | 5cd81fe1a21c0e1a7f0d5a62ddf8e422b05aedc7 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 4.17e-06 | 198 | 54 | 5 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | Bronchial_Biopsy-Endothelial|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.17e-06 | 198 | 54 | 5 | ec80b05b8a1800c341b5741bf3e57213308398a7 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.17e-06 | 198 | 54 | 5 | fb70a649e4e2edb32967328c1085dc5999c29a33 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Tumor_ECs|metastatic_Brain / Location, Cell class and cell subclass | 4.17e-06 | 198 | 54 | 5 | 5e274f29cc796dae7d64d6035e904816c25f9914 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.17e-06 | 198 | 54 | 5 | 71ee440b1ac566db63d0b415c50a0ad064d14f15 | |
| ToppCell | distal-3-Endothelial-Bronchial_Vessel_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.17e-06 | 198 | 54 | 5 | 00fdee373eaa43c9ce897f2ba2ecbe94cedea93a | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.27e-06 | 199 | 54 | 5 | 6a7ecc3a68b9cfc49e50abaeb16e2eee3795377e | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.27e-06 | 199 | 54 | 5 | 6fb81388c5045e81c3849a7136bdff3f953f044e | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Macrophage-Macrophages-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.37e-06 | 200 | 54 | 5 | e6d36be0c4c569e27303bb4e4f34cd2187e9759d | |
| ToppCell | Biopsy_Other_PF-Endothelial|Biopsy_Other_PF / Sample group, Lineage and Cell type | 4.37e-06 | 200 | 54 | 5 | f9916134486fb1dac55f5e7e8deb35e7a3b85770 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.37e-06 | 200 | 54 | 5 | 84e145619a500530f42ed0fe72468ae95f4cbf1e | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Macrophages|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.37e-06 | 200 | 54 | 5 | c0c51719cf81512c50bfcc2fed883c867e522d2a | |
| ToppCell | Biopsy_Other_PF-Endothelial-Endothelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 4.37e-06 | 200 | 54 | 5 | 40d57a383c79d3365e033d08efd9371f0bc5bf55 | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.37e-06 | 200 | 54 | 5 | 758840c31f2ddd7ccf7bf13252ebb48d33e89479 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.37e-06 | 200 | 54 | 5 | 27507c4b41d45c7cc50e4993169c0302be22ee34 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.37e-06 | 200 | 54 | 5 | cee07d9370656e1c428a7a9e9fbd175129901374 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Endothelial-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.37e-06 | 200 | 54 | 5 | b65fb8d378abd91cdabf5faac5f4b90d527f8c44 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.37e-06 | 200 | 54 | 5 | 2cb6e35add34b9dc564ebcf5d3cbc761325ca9f4 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.37e-06 | 200 | 54 | 5 | a3b09580738783c6bff31ea33d5188912e56b8a7 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.37e-06 | 200 | 54 | 5 | 310c75e13be9194312a8b686804edcf13d44caf5 | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Macrophage-Macrophages|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.37e-06 | 200 | 54 | 5 | c37fe06a94e5779c56e01389869bb432d3bbaebc | |
| ToppCell | LV-03._Atrial_Cardiomyocyte|LV / Chamber and Cluster_Paper | 1.37e-05 | 120 | 54 | 4 | 3b77bd0e3630cdd45001cecf5e47660a90ebc92e | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.56e-05 | 163 | 54 | 4 | ba7d02db0f0e2f9916ec8db52c067c87b6917c23 | |
| ToppCell | Endothelial-endothelial_cell_of_bronchial_vessel|World / Lineage, Cell type, age group and donor | 4.78e-05 | 165 | 54 | 4 | 84e553d699ac56df89a77248f7308b9133e1b683 | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l9|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.01e-05 | 167 | 54 | 4 | 38b1f052d663fa8f407c54bdd2060216f26feb0e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.13e-05 | 168 | 54 | 4 | 37249f38f8f04ec5743097259de67b106ca2b02f | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D175|Adult / Lineage, Cell type, age group and donor | 5.25e-05 | 169 | 54 | 4 | e1f0298236e4a1c59077c14f0dd29a78fac12648 | |
| ToppCell | Ionocyte-iono-1|World / Class top | 5.25e-05 | 169 | 54 | 4 | 4b68bcb4b5fc3cd2db23cd4edace7444aa2d605c | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel-D122|Adult / Lineage, Cell type, age group and donor | 5.37e-05 | 170 | 54 | 4 | a99cb3d21f8eb926886340ea99491e078e607648 | |
| ToppCell | Control-Endothelial_cells-Systemic_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 5.62e-05 | 172 | 54 | 4 | c55dce1ed3ed7312394b4e050e1de852a994e130 | |
| ToppCell | Endothelial-A-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 5.62e-05 | 172 | 54 | 4 | a3201773a25832e92dd113fad165f1ecd37f5e91 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-05 | 174 | 54 | 4 | 1c073177c1753e3b91ef8fd9e95230a1d13c82f3 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.88e-05 | 174 | 54 | 4 | 9f2e253694eb5860c00528fda31c305c6de8a2a1 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D231|Adult / Lineage, Cell type, age group and donor | 5.88e-05 | 174 | 54 | 4 | 2dd647c4fdf99fd1f7b838efef01baf2cbc3446d | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-05 | 174 | 54 | 4 | 5491ad5c144baf2ef9b1c58eb720c872d14feb15 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-D|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.01e-05 | 175 | 54 | 4 | c4088b5f9fa145869cf5dd8bee7680b1c8fada42 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-D-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.01e-05 | 175 | 54 | 4 | ca0d3e3a0a271cccdd3881b055fecb626712478d | |
| ToppCell | 356C-Endothelial_cells-Endothelial-D|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.28e-05 | 177 | 54 | 4 | a0b172f40e0df97a288a5549ae7066697ad469b3 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-D-|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.28e-05 | 177 | 54 | 4 | ab8f09e118e4df696b0b4d33f013da020bdbd351 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.42e-05 | 178 | 54 | 4 | 9fc5688cf705a74398d24e10e0aab4758612e72b | |
| ToppCell | Endothelial-A-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 6.42e-05 | 178 | 54 | 4 | 2f2602b9305d55f25afa9861dd6c6347ae179337 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.42e-05 | 178 | 54 | 4 | b863fc85d2449f25e6cea289459a7bb1f89583fd | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.70e-05 | 180 | 54 | 4 | 755050226eeb1991ee7f0d15e39d0458f3e4a791 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.70e-05 | 180 | 54 | 4 | 27e8bbee388e64dd79d70b160b76d45b1f398006 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 6.85e-05 | 181 | 54 | 4 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.85e-05 | 181 | 54 | 4 | cef034030e6b029a49ae56be37ea1fac1a5c350e | |
| Drug | Nf279 | 5.62e-06 | 15 | 54 | 3 | CID000004467 | |
| Disease | scoliosis (implicated_via_orthology) | 2.92e-05 | 5 | 51 | 2 | DOID:0060249 (implicated_via_orthology) | |
| Disease | alkaline phosphatase measurement | 5.40e-05 | 1015 | 51 | 9 | EFO_0004533 | |
| Disease | argininate measurement | 8.15e-05 | 8 | 51 | 2 | EFO_0800055 | |
| Disease | Paroxysmal atrial fibrillation | 1.55e-04 | 156 | 51 | 4 | C0235480 | |
| Disease | familial atrial fibrillation | 1.55e-04 | 156 | 51 | 4 | C3468561 | |
| Disease | Persistent atrial fibrillation | 1.55e-04 | 156 | 51 | 4 | C2585653 | |
| Disease | Atrial Fibrillation | 1.71e-04 | 160 | 51 | 4 | C0004238 | |
| Disease | cortical surface area measurement | RSPO3 ADAMTSL1 ADAMTS9 INPP5E ACKR3 ENPP3 RP1L1 PKHD1 MED13L | 4.46e-04 | 1345 | 51 | 9 | EFO_0010736 |
| Disease | Congenital hernia of foramen of Morgagni | 4.92e-04 | 19 | 51 | 2 | C0265699 | |
| Disease | Congenital hernia of foramen of Bochdalek | 4.92e-04 | 19 | 51 | 2 | C0265700 | |
| Disease | bone density | 5.48e-04 | 388 | 51 | 5 | EFO_0003923 | |
| Disease | Congenital diaphragmatic hernia | 6.02e-04 | 21 | 51 | 2 | C0235833 | |
| Disease | body surface area | 8.19e-04 | 643 | 51 | 6 | EFO_0022196 | |
| Disease | serum gamma-glutamyl transferase measurement | 9.44e-04 | 914 | 51 | 7 | EFO_0004532 | |
| Disease | hematocrit | 1.69e-03 | 1011 | 51 | 7 | EFO_0004348 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LVNTFCQSCIPDTVW | 421 | P08173 | |
| WTSCVIKDNPFCEFI | 471 | Q8WXK1 | |
| VCAIWIPEVCFANTV | 291 | Q9ULD4 | |
| QEVTSVCWCPSDFTK | 361 | Q9NZJ0 | |
| VTAVSEVFLCCEQGW | 481 | Q96AA3 | |
| EEEGDTCTICLEQWT | 281 | Q6PCD5 | |
| TWDFVDPTQRVSCSC | 411 | Q71F56 | |
| LIWFCSEVECSTVTT | 381 | Q9NRR6 | |
| FNVSVVNTTCFWIEC | 71 | Q04900 | |
| VCTFENENTEWCLAV | 1971 | Q38SD2 | |
| FIPEAWSACTVTCGV | 526 | Q8N6G6 | |
| ITSDWCFSCIHIEPV | 166 | Q9Y2G8 | |
| WCSPLDQVCISNEVV | 46 | H3BQJ8 | |
| WTEEVPSCQVVKCSS | 481 | P16581 | |
| CEVYDPATETWTELC | 451 | Q8IXQ5 | |
| TCEVSAWCPIEAVEE | 161 | Q99572 | |
| SCSLQPCEYVWITGE | 1606 | Q9P2N4 | |
| CCWDFEDTCVESTRI | 81 | O14638 | |
| CEEWVCDEPKDQTVV | 161 | P29279 | |
| VYSVTCEQCWPESGE | 361 | P29317 | |
| TPVIRAEDCTVCWNT | 3806 | Q8N3K9 | |
| DISWPCNSSDCIVVD | 16 | P25106 | |
| SACTDSWRVVDCPES | 11 | P60014 | |
| CDDSWTIQEAEVVCR | 1911 | Q9UGM3 | |
| QEVEVCCPWELSTLV | 206 | Q5VWM4 | |
| ACEQVSWFPECTTEI | 151 | Q8N1G2 | |
| NCSTDLTWFEHIVPC | 171 | A6NK58 | |
| TCEIQGWCPTEVDTV | 146 | P56373 | |
| RPSSCISWEVVEATC | 446 | Q9Y4I5 | |
| SECDFVFEWETPVVC | 1781 | P11717 | |
| CCWENPQFSSTVLSE | 2306 | Q93008 | |
| NEIQFWVVTEICLCS | 821 | Q8WZA2 | |
| RVVQDCSFAVCTTGW | 76 | O60279 | |
| ICEDTECAVPEAWTL | 4246 | A2VEC9 | |
| CCAVFSEAPNSWIVE | 321 | Q7Z7L1 | |
| SCDIVNLTEASIWCE | 1236 | P08F94 | |
| PVVNDEMCDVCEVWT | 126 | Q9UPV7 | |
| VVCALWIPEVCFANT | 351 | P55201 | |
| SVDCSDCWLPVVKFI | 101 | Q8WYJ6 | |
| QEVEVCCPWELSTLV | 206 | Q5VXH5 | |
| FISSCPCWLEVIFNS | 411 | O15105 | |
| EVSVCFTSEEWACLG | 221 | O14709 | |
| DVWTLPDQCHTVTCQ | 1891 | P04275 | |
| VACSAALDCDPIWVS | 1506 | Q8IWN7 | |
| VPEGATWAEVTVCSC | 666 | P29144 | |
| ECVSIVHCEVSEWNP | 141 | Q9BXY4 | |
| WFVECQVSQCVSSSP | 121 | Q93038 | |
| VVCVEGPQSACEEFW | 226 | P57060 | |
| CRDCVFEAVSIWDIT | 1371 | Q96JM2 | |
| FVVCEECRITEWVSV | 401 | Q9GZT5 | |
| TVICVFNWAFEECPP | 161 | Q96LC7 | |
| WQTLRSCCVEDPSTV | 1536 | Q68DK2 | |
| CPFSCETQAWSIATI | 1511 | P35573 | |
| APSAVSECFKCEEWT | 1021 | P52179 |